BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 115744
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.115744
Defining endpoints in percutaneous cholecystostomy: Catheter management, patient survival, and long-term outcomes from a twelve-year retrospective study
Maryam Hassanesfahani, Dimitrios Giannis, Nana Marfo, Manpreet Kaur, Camille Mai-Phuong Tran Quang, Andrew Miele, Martine A Louis, Nageswara Rao Mandava
Maryam Hassanesfahani, Dimitrios Giannis, Nana Marfo, Manpreet Kaur, Camille Mai-Phuong Tran Quang, Martine A Louis, Nageswara Rao Mandava, Department of Surgery, Flushing Hospital Medical Center, MediSys Health Network, Flushing, Queens, NY 11355, United States
Andrew Miele, Research, Education & Innovation (REl), MediSys Health Network, Flushing, Queens, NY 11355, United States
Co-first authors: Maryam Hassanesfahani and Dimitrios Giannis.
Author contributions: Hassanesfahani M and Giannis D contributed equally to this work; Hassanesfahani M and Louis MA conceptualized and designed the study, supervised, and made critical revisions; Hassanesfahani M, Giannis D, Marfo N, Kaur M, Quang CMPT, Miele A conducted the extraction, analysis, and interpretation of data; Hassanesfahani M, Giannis D, Louis MA, Mandava NR drafted the original manuscript; all authors read and agreed to the submitted version of the manuscript. Hassanesfahani M and Giannis D contributed equally to this work as co-first authors.
Institutional review board statement: This study was reviewed and approved by the Flushing Hospital Medical Center Institutional Review Board, No. 2265474-1.
Informed consent statement: Informed consent was waived for this retrospective study of de-identified data.
Conflict-of-interest statement: All authors declare no conflict of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The authors confirm that the data supporting the findings of this study are available within the article.
Corresponding author: Dimitrios Giannis, MD, PhD, Department of Surgery, Flushing Hospital Medical Center, MediSys Health Network, 4500 Parsons Blvd, Flushing, Queens, NY 11355, United States. dimitrisgiannhs@gmail.com
Received: October 24, 2025
Revised: December 14, 2025
Accepted: December 25, 2025
Published online: February 27, 2026
Processing time: 125 Days and 16.7 Hours
Abstract
BACKGROUND

Percutaneous cholecystostomy (PCT) is widely used for high-risk acute cholecystitis as an alternative to emergent cholecystectomy. Despite its effectiveness, the optimal timing, catheter management, and long-term outcomes remain to be elucidated.

AIM

To characterize timing, catheter management, survival, and follow-up outcomes after PCT in a high-risk cohort.

METHODS

This single center retrospective cohort study included consecutive adult patients undergoing PCT placement for acute cholecystitis at a community hospital setting in New York between January 2012 and December 2024. The study population was grouped according to type of acute cholecystitis (calculous vs acalculous), according to the timing of PCT placement since diagnosis [early (≤ 4 days) vs late (> 4 days)], and according to level of care [intensive care unit (ICU) vs non-ICU patients]. Cox proportional hazards models were used to examine effects of PCT placement interval on mortality rates, after accounting for potential confounding factors (age, Charlson Comorbidity Index, cholecystitis type, ICU status, bile culture and blood culture data).

RESULTS

The population consisted of 174 patients who underwent PCT placement for acute cholecystitis between 2012 and 2024 at a community hospital in New York. Median time to PCT was 2 days (interquartile range 1-4). Overall, mortality was 21% (36/174) and was higher with delayed PCT (> 4 days) vs early PCT [35% (17/49) vs 15% (19/125), P = 0.001]. Catheter removal occurred in 13% (23/174), 55% (96/174) remained catheter-dependent, and 32% (56/174) had interval cholecystectomy. ICU admission was associated with prolonged catheter duration but was not associated with mortality. Kaplan-Meier analysis demonstrated a significantly higher survival rate in the early group compared with the late group (log-rank P = 0.006). In both unadjusted models and models adjusted for selected covariates, patients who had catheters placed late (> 4 days) had 2.5-fold higher risk of death than patients with early placement.

CONCLUSION

Early PCT was associated with higher survival in high-risk acute cholecystitis. High rates of catheter dependency highlight the need for standardized protocols and reassessment for definitive surgery.

Keywords: Percutaneous cholecystostomy; Acute gallstone cholecystitis; Acalculous cholecystitis; Catheter management; Cholelithiasis; Laparoscopic cholecystectomy

Core Tip: Percutaneous cholecystostomy (PCT) is commonly used as a bridge or alternative to surgery in high-risk patients with acute cholecystitis, yet optimal timing and catheter management remain uncertain. In this retrospective study of 174 patients, early PCT (≤ 4 days from diagnosis) was associated with significantly higher survival compared to delayed intervention. Despite its clinical benefit, more than half of patients remained catheter-dependent, and only one-third underwent interval cholecystectomy. These findings highlight the need for standardized PCT management protocols and structured follow-up to optimize long-term outcomes in this fragile population.